Page 69 - 《中国药房》2026年4期
P. 69
parenteral nutrition with fluconazole[J]. Nutrition,2024, [16] LIM T P,HEE D K,LEE W,et al. Physicochemical stabi-
123:112417. lity study of polymyxin B in various infusion solutions for
[ 3 ] LIU Y G,LIAO M H,SANG X Q,et al. A case of precipi‐ administration to critically ill patients[J]. Ann Pharmaco‐
tate in intravenous line when general anesthesia imple‐ ther,2016,50(9):790-792.
mented with remimazolam[J]. Heliyon,2022,8(12): [17] TSIOURIS M,ULMER M,YURCHO J F,et al. Stability
e12491. and compatibility of reconstituted caspofungin in select
[ 4 ] BRADLEY J S,WASSEL R T,LEE L,et al. Intravenous elastomeric infusion devices[J]. Int J Pharm Compd,
ceftriaxone and calcium in the neonate:assessing the risk 2010,14(5):436-439.
for cardiopulmonary adverse events[J]. Pediatrics,2009, [18] CURTI C,SOUAB H K,LAMY E,et al. Stability studies
123(4):e609-e613. of antipyocyanic beta-lactam antibiotics used in continuous
[ 5 ] BARG N L,SUPENA R B,FEKETY R. Persistent staphy‐ infusion[J]. Pharmazie,2019,74(6):357-362.
lococcal bacteremia in an intravenous drug abuser[J]. Anti‐ [19] SORNSUVIT C,WIENTONG P,UITRAKUL S,et al. In‐
microb Agents Chemother,1986,29(2):209-211. fluence of concentration and temperature on stability of
[ 6 ] MARSILIO N R,DA SILVA D,BUENO D. Drug incom‐ imipenem focused on solutions for extended infusion[J].
patibilities in the adult intensive care unit of a university Dose Response,2021,19(4):15593258211059325.
hospital[J]. Rev Bras Ter Intensiva,2016,28(2):147-153. [20] 郑晨,王钰,何晓静,等. 对头孢他啶注射液稳定性的影
[ 7 ] LESSARD J J,CARON E,SCHÉRER H,et al. Compa- 响因素研究[J]. 中国临床药理学杂志,2017,33(23):
tibility of Y-site injection of meropenem trihydrate with 2443-2445.
101 other injectable drugs[J]. Hosp Pharm,2020,55(5): [21] CAVASSIN F B,BAÚ-CARNEIRO J L,VILAS-BOAS R
332-337. R,et al. Sixty years of amphotericin B:an overview of the
[ 8 ] Truven Health Analytics. Micromedex[DB/OL]. [2025-02- main antifungal agent used to treat invasive fungal infec‐
15]. https://www.micromedexsolutions.com. tions[J]. Infect Dis Ther,2021,10(1):115-147.
[ 9 ] GIMÉNEZ-GINER S,LLOPIS-ALEMANY A,PORTA- [22] 吕薛,胡立宏. 两性霉素B的结构修饰研究进展[J]. 药学
OLTRA B,et al. Chemical stability and physical compa- 研究,2016,35(11):621-627.
tibility of meropenem in admixtures for continuous and [23] RAVERDY V,AMPE E,HECQ J D,et al. Stability and
extended intravenous infusions[J]. Enferm Infecc Micro‐ compatibility of vancomycin for administration by con‐
biol Clin(Engl Ed),2023,41(10):612-616. tinuous infusion[J]. J Antimicrob Chemother,2013,68
[10] KEEL R A,SUTHERLAND C A,CRANDON J L,et al. (5):1179-1182.
Stability of doripenem,imipenem and meropenem at ele- [24] MEYER K,SANTAROSSA M,DANZIGER L H,et al.
vated room temperatures[J]. Int J Antimicrob Agents, Compatibility of ceftazidime-avibactam, ceftolozane-
2011,37(2):184-185. tazobactam,and piperacillin-tazobactam with vancomycin
[11] MEHTA S,ARMSTRONG B K,KIM S J,et al. Long- in dextrose 5% in water[J]. Hosp Pharm,2017,52(3):
term potency,sterility,and stability of vancomycin,cef‐ 221-228.
tazidime,and moxifloxacin for treatment of bacterial en‐ [25] LEUNG E,VENKATESAN N,LY S C,et al. Physical
dophthalmitis[J]. Retina,2011,31(7):1316-1322. compatibility of vancomycin and piperacillin sodium-
[12] WALKER S E,IAZZETTA J,LAW S,et al. Stability of tazobactam at concentrations typically used during pro‐
commonly used antibiotic solutions in an elastomeric infu‐ longed infusions[J]. Am J Health Syst Pharm,2013,70
sion device[J]. Can J Hosp Pharm,2010,63(3):212-224. (13):1163-1166.
[13] DONNELLY R F. Stability of aseptically prepared tazocin [26] CONDIE C K,TYLER L S,BARKER B,et al. Visual
solutions in polyvinyl chloride bags[J]. Can J Hosp compatibility of caspofungin acetate with commonly used
Pharm,2009,62(3):226-231. drugs during simulated Y-site delivery[J]. Am J Health
[14] SAHRAOUI L,CHIADMI F,SCHLATTER J,et al. Sta‐ Syst Pharm,2008,65(5):454-457.
bility of voriconazole injection in 0.9% sodium chloride [27] O’DONNELL J N,VENKATESAN N,MANEK M,et al.
and 5% dextrose injections[J]. Am J Health Syst Pharm, Visual and absorbance analyses of admixtures containing
2006,63(15):1423-1426. vancomycin and piperacillin-tazobactam at commonly
[15] HE J,FIGUEROA D A,LIM T P,et al. Stability of poly‐ used concentrations[J]. Am J Health Syst Pharm,2016,73
myxin B sulfate diluted in 0.9% sodium chloride injection (4):241-246.
and stored at 4 or 25 degrees C[J]. Am J Health Syst (收稿日期:2025-08-15 修回日期:2026-01-22)
Pharm,2010,67(14):1191-1194. (编辑:孙 冰)
中国药房 2026年第37卷第4期 China Pharmacy 2026 Vol. 37 No. 4 · 475 ·

